After a strong start to the year, with the Canadian Cannabis LP Index rising 17.7% in January, the benchmark reversed out the gains in February, declining 18.6% to leave...
Cronos Group to Begin Trading on Nasdaq Stock Exchange TORONTO, Feb. 26, 2018 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC Nasdaq Int’l Designation: PRMCF) (“Cronos Group” or the...
Cronos Group Announces Launch of Cronos Australia with Grant of Two Licenses TORONTO, Feb. 5, 2018 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC Nasdaq Int’l Designation: PRMCF) (the “Group” or...
Peace Naturals Receives Dealer’s License Allowing for the Exportation of New Product Categories Cronos Group Inc. (TSXV: MJN) (OTC – Nasdaq Int’l Designation: PRMCF) (“Cronos Group” or the “Company”)...
In 2017, the first two exchange-traded funds (ETF) focused on publicly-traded cannabis stocks emerged, including Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (TSX: HMMJ.U) (OTC: HMLSF) in April...
Cronos Group Inc. Announces $30 Million Bought Deal TORONTO, Jan. 2, 2018 /CNW/ – Cronos Group Inc. (TSX VENTURE: MJN) (“Cronos” or the “Company”) is pleased to announce that it has entered into a...
Health Canada has issued 84 licenses to date under Authorized Licensed Producers of Cannabis for Medical Purposes (ACMPR) and has indicated that it will ramp up to over 200 in...
Cannabis stocks surged 51.8% in December after a 58.3% gain in November. For the full year, the Cannabis Stock Index rose from 74.10 to 142.10, an increase of 91.8%: Like...
Cronos Group Inc. Reports Q3 2017 Financial Results 962% increase in Q3 2017 revenue over the comparable prior year period Establishing low-cost capacity through joint venture in Israel Strengthened...
Cronos Group Announces Closing of Previously Announced $17 Million Bought Deal TORONTO, Nov. 8, 2017 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int’l Designation: PRMCF) (“Cronos...
Despite a flood of supply this month, Canadian LP stock performance stands out so far in October as investors have retreated somewhat from the overall sector. The Cannabis Stock...
Cronos Group Inc. Announces $15 Million Bought Deal TORONTO, Oct. 19, 2017 /CNW/ – Cronos Group Inc. (TSX VENTURE: MJN) (“Cronos” or the “Company”) is pleased to announce that...
Expansion of International Medical Cannabis Markets: Poland Guest post by Peter S. Murphy, Member, Eckert Seamans Cherin & Mellott, LLC This Summer, Poland became the twelfth country in the European...
Cronos Announces Exclusive Distribution Agreement with Pohl-Boskamp in Germany TORONTO, Oct. 12, 2017 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int’l Designation: PRMCF) (“Cronos” or the...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...
Cronos Announces Private Placement of Common Shares TORONTO, Sept. 14, 2017 /CNW/ – Cronos Group Inc. (“Cronos” or the “Company”) (TSX Venture: MJN) (OTC – Nasdaq International Designation: PRMCF)...
Cronos Establishes International Low Cost Production in Israel TORONTO, Sept. 6, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased to announce...
The Cronos Group (TSXV: MJN) (OTC: PRMCF), which owns Canadian licensed producers Peace Naturals and In the Zone and has several other investments among LPs, had a management change...
Cronos Group Secures $40M in Debt for Domestic Capacity Expansion TORONTO, Aug. 24, 2017 /CNW/ – Cronos Group Inc. (TSXV:MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is announcing today...
After a big 2nd half of 2016 and some strength in early 2017, Canadian LPs were under heavy pressure from April through June following a glut of supply (new...
Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products...
Cronos Breaks Ground on World’s Largest Purpose-Built Indoor Cannabis Facility TORONTO, May 23, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased...
Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the...
Statement from Health Canada on Mandatory Testing of Medical Cannabis for Unauthorized Pesticides OTTAWA, May 5, 2017 /CNW/ – Health Canada is committed to protecting the health and safety...
While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR...
